APEX1 and glioblastoma: A recent study on exceptional responders to TMZ treatment in GBM, following surgery and radiation, identified the inactivation of APE1 as a source for the exceptionally strong treatment response over 10 years, thus highlighting the promise of APE1 inhibitors in GBM treatment with TMZ [71].